Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival

✍ Scribed by van Besien, K; Rodriguez, A; Tomany, S; Younes, A; Donato, M; Sarris, A; Giralt, S; Mehra, R; Andersson, B; Gajewski, J

• Book ID: 110012955
• Publisher: Nature Publishing Group
• Year: 2001
• Tongue: English
• Weight: 96 KB
• Volume: 27
• Category: Article
• ISSN: 0007-1188
• DOI: 10.1038/sj.bmt.1702793